(Q45880345)

17 December 2017

title

Guidelines for the management of hemophilia (English)

1 reference

17 December 2017

0 references

A Srivastava

1

1 reference

17 December 2017

A K Brewer

2

1 reference

17 December 2017

E P Mauser-Bunschoten

3

1 reference

17 December 2017

N S Key

4

1 reference

17 December 2017

S Kitchen

5

1 reference

17 December 2017

A Llinas

6

1 reference

17 December 2017

C A Ludlam

7

1 reference

17 December 2017

J N Mahlangu

8

1 reference

17 December 2017

K Mulder

9

1 reference

17 December 2017

M C Poon

10

1 reference

17 December 2017

A Street

11

1 reference

17 December 2017

Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia

12

1 reference

17 December 2017

publication date

6 July 2012

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

e1-47

1 reference

17 December 2017

Venous access in haemophilic children: choice and management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Hemophilia in the 1990s: principles of management and improved access to care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The natural evolution of haemophilia care: developing and sustaining comprehensive care globally

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Comprehensive care for haemophilia around the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Orthopaedic issues in sports for persons with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Prophylaxis in adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haemophilia care in adolescents--compliance and lifestyle issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Home management of haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Resource utilisation in haemophiliacs treated in Europe: results from the European Study on Socioeconomic Aspects of Haemophilia Care. The European Socioeconomic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Central venous access devices in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The risk associated with indwelling catheters in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Long-term major joint outcomes in young adults with haemophilia: interim data from the HGDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Influence of aquatic training on the motor performance of patients with haemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Surgery and inhibitor development in hemophilia A: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Patterns of bleeding in adolescents with severe haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Detection of Carriers of Haemophilia: a ‘Blind’ Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Bleeding in carriers of hemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Genetic counseling of hemophilia carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Carrier testing in haemophilia A and B: adult carriers' and their partners' experiences and their views on the testing of young females

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Non-invasive tool for foetal sex determination in early gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Earliest gestational age for fetal sexing in cell-free maternal plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Chorionic villus sampling and amniocentesis in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Update on Procedure-Related Risks for Prenatal Diagnosis Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Invasive prenatal diagnostic techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and rise in maternal serum alpha feto protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Preimplantation genetic diagnosis of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Perinatal management of newborns with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Counselling about diagnosis and inheritance of genetic bleeding disorders: haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Psycho-social determinants of quality of life in children and adolescents with haemophilia-a cross-cultural approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Osteoporosis in haemophilia - an underestimated comorbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Hemophilia, low bone mass, and osteopenia/osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Obesity: a new disaster for haemophilic patients? A nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Cardiovascular risk assessment in haemophilia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haemophilia protects against ischaemic heart disease: a study of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Prevalence and risk factors for heart disease among males with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

How I treat age-related morbidities in elderly persons with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Cardiovascular disease in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The management of cardiovascular diseases in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

21 January 2018

Haemophilia and ageing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of inherited von Willebrand disease in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Pathogenesis of venous thromboembolism: when the cup runneth over

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Blood products for hemophilia: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Nanofiltration of plasma-derived biopharmaceutical products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Surveillance for transfusion-transmitted viral infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Products for clotting factor replacement in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

DDAVP-induced hyponatremia in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Hyponatremia and seizures in young children given DDAVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

FEIBA safety profile in multiple modes of clinical and home-therapy application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Controlled trial of joint aspiration in acute haemophilic haemarthrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Current practice in the management of muscle haematomas in patients with severe haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Emergency department care for patients with hemophilia and von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Controversial subjects in musculoskeletal care of haemophilia: cross fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Orthopedic management in hemophilia: a Spanish outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Iliopsoas haemorrhage in patients with haemophilia: results from one centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intracranial haemorrhage in haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intracranial hemorrhage in children with congenital factor deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The clinical management of hemophilia and head trauma: a survey of current clinical practice among pediatric hematology/oncology physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

21 January 2018

Hemophilia emergencies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Emergency care of the hemophiliac patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

How do we treat: upper gastrointestinal bleeding in adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haematuria and urolithiasis in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Domiciliary application of CryoCuff in severe haemophilia: qualitative questionnaire and clinical audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

21 January 2018

Haemophilic arthropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Musculoskeletal complications of hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Aspects of current management: orthopaedic surgery in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Rehabilitation of synovitis in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Prophylaxis in haemophilia: a double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Comprehensive elements of a physiotherapy exercise programme in haemophilia--a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Exercise and sport in the treatment of haemophilic patients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Current concepts in electrotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Functional recovery after bleeding episodes in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

21 January 2018

Orthoses in haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The role of synovectomy in the management of a target joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Arthroscopic synovectomy in haemophilic arthropathy of the knee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Radioactive synovectomy with Yttrium⁹⁰ citrate in haemophilic synovitis: Brazilian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haemophilic arthropathy: the usefulness of intra-articular oxytetracycline (synoviorthesis) in the treatment of chronic synovitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Chemical synoviorthesis with rifampicin in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Refinement of a sonographic protocol for assessment of haemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Sonography for assessment of haemophilic arthropathy in children: a systematic protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of arthrofibrosis in haemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Non-operative treatment of flexion contracture of the knee in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of fixed flexion contracture of the elbow in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Models for psychosocial services in the developed and developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Arthroscopic synovectomy: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Total knee replacement in patients with end-stage haemophilic arthropathy: 25-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Radial head excision and synovectomy in patients with hemophilia. Surgical technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Arthrodesis of the ankle and subtalar joints in patients with haemophilic arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The role of physiotherapy after total knee arthroplasty in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Surgery for hemophilia in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Physiotherapy following elective orthopaedic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The role of physical therapy and rehabilitation in the management of hemophilia in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Conservative physiotherapeutic management of chronic haematomata and haemophilic pseudotumours: case study and comparison to historical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Rheumatological management of patients with hemophilia. Part II: Muscle hematomas and pseudotumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Management of haemophilic pseudotumours with special emphasis on radiotherapy and arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Bone fractures in the haemophilic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Fracture neck of femur in haemophilia A - experience from a cohort of 11 patients from a tertiary centre in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Retrograde intramedullary nailing of supracondylar femoral fractures in haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

External fixators in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Fibrin glue and clinical impact on haemophilia care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The epidemiology of inhibitors in haemophilia A: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The between-laboratory variation of factor VIII inhibitor testing: the experience of the external quality assessment program of the ECAT foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Recommendations for assessment, monitoring and follow-up of patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

European principles of haemophilia care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

International workshop on immune tolerance induction: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Immune tolerance induction in haemophilia: evidence and the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

The principal results of the International Immune Tolerance Study: a randomized dose comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Morbidity and mortality from transfusion-transmitted disease in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Plasma fractionation issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Emerging and receding risks of therapeutic regimens for haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Emerging viral diseases and infectious disease risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Preliminary study of two antiviral agents for hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Hepatitis A and B immunization for individuals with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Immune response of patients with congenital coagulation disorders to hepatitis B vaccine: suboptimal response and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A long-term follow-up of hepatitis B vaccination in patients with congenital clotting disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Hemophilia A, idiopathic thrombocytopenia and HTLV-III-infection impressive remission after splenectomy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Septic arthritis in males with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Orthopaedic surgery of haemophilia in the 21st century: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Prophylaxis in the haemophilia population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

Bone mineral density in haemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02909.X

10.1111/J.1365-2516.2012.02909.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017